Charcot-Marie-Tooth disease caused by mutation in IGHMBP2 is a rare inherited nerve disease where damage starts in the long nerves of the legs and arms. It belongs to the “axonal” group of Charcot-Marie-Tooth (CMT) diseases and is usually called CMT type 2S (CMT2S). In this condition, both copies of the IGHMBP2 gene are changed, so the body makes too little or faulty IGHMBP2 protein, and the long nerves slowly stop working properly. Cell+1
Charcot-Marie-Tooth disease (CMT) caused by mutation in the IGHMBP2 gene is a rare, inherited nerve disease. It affects the peripheral nerves that carry signals from the spinal cord to the muscles and skin. The IGHMBP2 gene normally helps nerve cells handle DNA and RNA and make healthy proteins. When this gene is faulty, the long nerves in the legs and arms slowly become weak and damaged. People often develop foot deformities, weak ankles, walking problems, and reduced feeling in the feet and hands. This IGHMBP2-related CMT form is usually called CMT2S, a severe axonal type of CMT. It can overlap with another IGHMBP2-related disorder called spinal muscular atrophy with respiratory distress (SMARD1).Frontiers+1
The IGHMBP2 gene gives instructions to make an enzyme that works as a helicase. A helicase is a helper protein that unwinds DNA or RNA so the cell can copy or read genetic information. When IGHMBP2 is faulty, nerve cells, especially motor and sensory nerves, cannot handle their normal work and become sick over time, leading to weakness, wasting of muscles, and loss of feeling, mainly in the feet and hands. MedlinePlus+2PMC+2
Mutations in IGHMBP2 can cause a spectrum of diseases. At one end is SMARD1 (spinal muscular atrophy with respiratory distress type 1), a severe infant disease with breathing failure. At the milder end is CMT2S, where breathing is usually preserved, but there is slowly progressive weakness and sensory loss in the limbs. Which disease appears often depends on the exact type and place of the mutation in the IGHMBP2 gene. Frontiers+2PMC+2
Another names
This disease and the related gene can appear under several names in reports and genetic tests. Knowing these names helps you recognize the same condition in different articles or lab reports. NCBI+1
Charcot-Marie-Tooth disease type 2S (CMT2S) – This is the most common name used in neurology for IGHMBP2-related CMT, showing it is a type 2 (axonal) hereditary neuropathy. Cell+1
IGHMBP2-related Charcot-Marie-Tooth disease – This name connects the clinical disease (CMT) directly with the gene that is mutated (IGHMBP2). Europe PMC+1
Autosomal recessive axonal CMT due to IGHMBP2 – This phrase explains that the disease is inherited as an autosomal recessive trait and mainly affects the axon part of the nerve. Nature+1
IGHMBP2-related axonal sensorimotor neuropathy – Some papers describe it this way, to stress that both movement (motor) and feeling (sensory) nerves are affected. PubMed+1
Hereditary motor and sensory neuropathy due to IGHMBP2 mutation – This is a descriptive name that tells you it is a genetic disease affecting motor and sensory nerves and that IGHMBP2 is the cause. Europe PMC+1
IGHMBP2-associated neuromuscular disease – Review articles sometimes use this broad label to include both SMARD1 and CMT2S caused by IGHMBP2 mutations. Frontiers+1
Types
Doctors do not divide CMT2S into many strict subtypes yet, but they do see patterns based on age of onset, severity, and which nerves are more affected. These patterns are helpful when talking about prognosis and family counseling. Nature+1
Early-onset CMT2S – Symptoms start in early childhood, often before school age. Children may walk late, fall often, or have very thin legs. Disease is usually more severe in this group, with earlier foot deformities and more marked weakness. PubMed+1
Childhood / adolescent-onset CMT2S – Many patients develop problems in late childhood or teenage years, such as difficulty running, frequent ankle sprains, and foot drop. Progression tends to be slow but continuous over many years. Cell+1
Late-onset CMT2S – A few patients develop symptoms in adulthood. They may notice slowly progressive foot weakness or sensory loss, sometimes mistaken for other neuropathies. These cases may be milder and progress more slowly. ScienceDirect+1
Mild vs. moderate-to-severe CMT2S – Even with the same gene involved, some people have mild disability and walk independently for life, while others need walking aids or wheelchairs. The type of mutation and its location in the gene often influence this severity. Frontiers+2Wiley Online Library+2
Overlap toward SMARD1 end of the spectrum – In rare cases, IGHMBP2 mutations may cause features in between classic CMT2S and SMARD1, such as neuropathy plus some breathing problems. This shows how the same gene can cause a range of nerve diseases. Frontiers+2JKMS+2
Causes
The main cause of this disease is having two disease-causing mutations in the IGHMBP2 gene (one from each parent). Other points below describe types of mutations and factors that influence how the disease appears or how severe it becomes. MedlinePlus+2Cell+2
Autosomal recessive IGHMBP2 mutations – CMT2S usually appears when a person inherits one faulty IGHMBP2 gene from the mother and one from the father. Each parent is often healthy but carries one mutated copy, while the child who gets both mutated copies develops disease. Cell+1
Missense mutations in the helicase domain – Many patients have a change in a single “letter” of the DNA code (missense variant) in the helicase core of IGHMBP2. This can weaken the enzyme’s ability to unwind DNA/RNA and support normal nerve function. PMC+2ScienceDirect+2
Truncating (nonsense or frameshift) mutations – Some mutations introduce a premature stop signal or shift the reading frame, producing a shortened, non-working IGHMBP2 protein. These truncating changes can strongly reduce protein levels in cells and cause neuropathy. Cell+1
Compound heterozygous mutations – Many patients have two different IGHMBP2 mutations (one on each gene copy). The combined effect of these two variants can damage the helicase enough to cause CMT2S, even if each single change might be milder alone. PubMed+1
Mutations in the 5′ region of the gene – Changes in the front (5′) part of the gene can affect how the protein starts or folds. Clinical studies suggest these 5′ mutations are more often linked to CMT2S than to the very severe SMARD1 form. Frontiers+1
Mutations in the last exon – Variants in the last exon (end segment) of IGHMBP2 are also frequently reported in CMT2S. They may disturb important tail regions of the protein that are needed for normal nerve survival but in a way that is less aggressive than in SMARD1. Frontiers+2PMC+2
Reduced IGHMBP2 protein stability – Some mutations do not change the active site directly but make the protein unstable so it is broken down faster by the cell. Lower levels of functional helicase over many years can gradually damage motor and sensory neurons. Europe PMC+1
Defects in ribosome-associated function – IGHMBP2 also works near ribosomes, where proteins are made. When this function is lost, the quality of mRNA translation in neurons can drop, making nerve cells more vulnerable and leading to neuropathy. ScienceDirect+1
Disrupted DNA/RNA processing in motor neurons – Because IGHMBP2 is a helicase, mutations can interfere with DNA/RNA handling during cell division and gene expression. This is particularly harmful in long motor neurons, which depend on accurate RNA processing to stay healthy. PMC+1
Consanguinity (parents related to each other) – In some families, the parents are related (for example, cousins). This increases the chance that both parents carry the same rare IGHMBP2 mutation, so a child can inherit two copies and develop CMT2S. PubMed+2Nature+2
Founder mutations in certain populations – A “founder” mutation is an old genetic change that has spread in a specific group over many generations. Such founder IGHMBP2 mutations can make CMT2S more frequent within that group, even while still being rare overall. PubMed+2Nature+2
Genetic modifiers in other genes – Some people with the same IGHMBP2 mutation have different severity. Other genes that affect nerve health or stress responses may modify how strongly the IGHMBP2 defect shows, although these modifiers are not yet fully known. Frontiers+2Wiley Online Library+2
Cell stress and impaired protein homeostasis – Lab studies suggest that loss of IGHMBP2 can disturb how cells deal with mis-folded proteins and stress. Over time, this imbalance can contribute to nerve degeneration in people with IGHMBP2 mutations. life-science-alliance.org+1
Mitochondrial stress secondary to helicase dysfunction – While mitochondria are not directly mutated, chronic problems with DNA/RNA handling can strain energy production systems. Nerve cells are very sensitive to low energy, so they may degenerate more easily when IGHMBP2 is defective. (This is a proposed mechanism from experimental work, not a proven separate cause.) PMC+1
Oxidative and metabolic stress in neurons – Animal and cellular models of IGHMBP2-related disease show increased signs of stress pathways. These stresses add to the direct genetic defect and may speed up nerve damage over time. NMD Journal+1
Delay in diagnosis and lack of supportive care – This does not cause the mutation, but late recognition of CMT2S means patients may fall more, develop worse deformities, and lose strength faster because they do not receive timely therapy and orthotic support. pfmjournal.org+1
Co-existing neuropathy causes (e.g., diabetes, toxins) – In a patient with IGHMBP2 mutations, additional nerve injuries such as long-term diabetes, heavy alcohol use, or nerve-toxic drugs can worsen symptoms, even though they are not the original genetic cause. pfmjournal.org+1
Poor general nutrition – Malnutrition or vitamin deficiencies (for example, low B12) can add extra stress to already damaged nerves and may worsen weakness and numbness in people with IGHMBP2-related CMT. pfmjournal.org+1
Physical overuse and repeated ankle injuries – High-impact sports or repeated ankle sprains do not cause CMT2S, but when nerves are fragile they can increase pain, instability, and deformities such as pes cavus, adding to disability. pfmjournal.org+1
Unknown or not yet identified factors – Even with modern testing, doctors sometimes cannot explain why one person with IGHMBP2 mutations is more affected than another. This suggests that other genetic and environmental factors play a role, but they are still being studied. Frontiers+2Wiley Online Library+2
Symptoms (15 key symptoms explained)
Symptoms usually develop slowly and start in the feet and legs, then later involve the hands. Many signs are similar to other forms of Charcot-Marie-Tooth disease, but the genetic cause is specifically in IGHMBP2. Cell+2IJB Management+2
Weakness in the feet and ankles – People often notice trouble lifting the front of the foot (foot drop). They may trip on uneven ground or have difficulty climbing stairs because the ankle muscles are too weak. Cell+1
Thin (wasted) lower leg muscles – Over time, the muscles of the calves become thin because the nerves that supply them are damaged. This gives a “stork leg” or “inverted champagne bottle” look. pfmjournal.org+1
Foot deformities (high arches or hammertoes) – Many patients develop pes cavus (very high arches) or curled toes (hammertoes). These deformities come from long-term imbalance between weak and stronger muscles around the foot. pfmjournal.org+2MedlinePlus+2
Frequent ankle sprains and falls – Instability of the ankle and weakness of the foot muscles make it easy to twist the ankle or fall, especially on uneven ground or in the dark. pfmjournal.org+1
Numbness or reduced feeling in the feet – Sensory nerves are affected, so people may feel tingling, burning, or reduced sensation to touch, pain, or temperature in the toes and soles. Cell+2MedlinePlus+2
Weakness in the hands and fingers – As the disease progresses upward, hand muscles may weaken. Patients may struggle with buttons, zippers, handwriting, or holding small objects tightly. Cell+1
Cold-induced cramps and stiffness – Some people report hand or leg cramps that are worse in cold weather. This may be due to nerve dysfunction and changed muscle control. pfmjournal.org+1
Loss of vibration and position sense – Vibration sense at the ankles and position sense of the toes and fingers can decline. Patients may not know exactly where their feet are without looking, which worsens balance. pfmjournal.org+1
Reduced or absent reflexes – When the doctor taps the knee or ankle with a hammer, the usual “jerk” may be weak or absent, because the reflex arc through the peripheral nerve is damaged. pfmjournal.org+1
Balance problems and unsteady walking – Weak muscles, poor sensation, and foot deformities together lead to wobbly walking. People may widen their stance or avoid walking in the dark to keep from falling. pfmjournal.org+2MedlinePlus+2
Fatigue with long walking or standing – Because muscles are weak and nerves are damaged, standing or walking for a long time is tiring. Patients may need frequent rests or use walking aids over time. Cell+1
Pain or uncomfortable sensations – Some patients have nerve pain, burning, or electric-shock feelings in their feet or hands. Others may feel only mild discomfort or tightness. pfmjournal.org+1
Scoliosis or spinal posture problems (in some cases) – In a few patients, muscle imbalance around the spine may lead to a curved back or posture changes, though this is less common than in SMARD1. JKMS+1
Mild breathing or chest weakness (rare in CMT2S) – Classic CMT2S usually does not cause severe breathing failure, unlike SMARD1. However, some patients with IGHMBP2 mutations have milder respiratory muscle weakness or reduced cough strength. JKMS+2IJB Management+2
Slow, lifelong progression – The disease usually progresses slowly. Many patients remain able to walk for decades, though they may need orthoses or walking aids as they age. Cell+2Nature+2
Diagnostic tests (20 tests in 5 groups)
Diagnosis combines the story of symptoms, neurologic exam, nerve tests, and genetic testing. These steps help confirm CMT2S and rule out other causes of neuropathy. pfmjournal.org+2Cell+2
Physical exam tests
General neurological examination – The doctor checks muscle strength, tone, reflexes, and sensation in all limbs. The pattern of distal weakness, sensory loss, and reduced reflexes suggests an axonal CMT and guides further testing. pfmjournal.org+1
Gait and posture assessment – Walking is observed for foot drop, high-stepping gait, and balance problems. Standing on heels or toes may be tested; difficulty often points to weakness in specific muscle groups typical of CMT. pfmjournal.org+2MedlinePlus+2
Inspection of feet and hands – The doctor looks for high arches, hammertoes, calluses, and wasting of small hand muscles. These visible signs support a long-standing neuropathy rather than a short-term nerve injury. pfmjournal.org+1
Spine and chest evaluation – Posture, spinal curve, and chest movement are checked. This helps identify scoliosis or subtle breathing muscle weakness, which may appear in some IGHMBP2-related cases. JKMS+1
Manual (bedside) tests
Manual muscle testing (MRC grading) – The examiner asks the patient to push or pull against resistance and grades strength from 0 to 5. Distal muscles in the feet and hands typically show lower grades, matching the pattern of CMT2S. Cell+1
Deep tendon reflex testing – Using a reflex hammer, the doctor checks knee and ankle jerks, plus reflexes in the arms. Weak or absent reflexes, especially at the ankles, are common in CMT and support peripheral nerve damage. pfmjournal.org+1
Vibration sense testing with a tuning fork – A tuning fork is placed on the toes and ankles to see if the patient can feel the vibration. Loss of vibration sense is a simple sign of large-fiber sensory nerve involvement. pfmjournal.org+1
Romberg and balance tests – The patient is asked to stand with feet together, then with eyes closed. Increased sway or falling with eyes closed shows that joint position sense is poor, a common feature in length-dependent neuropathies. pfmjournal.org+1
Lab and pathological tests
Basic blood tests (glucose, kidney, liver, vitamins) – These tests help rule out common acquired causes of neuropathy, such as diabetes, kidney failure, liver disease, and vitamin B12 deficiency, so that inherited CMT can be recognized more clearly. pfmjournal.org+1
Thyroid function tests – Low or high thyroid hormone levels can cause neuropathy. Checking thyroid function ensures that symptoms are not due to a treatable thyroid problem instead of or in addition to CMT. pfmjournal.org+1
Serum creatine kinase (CK) – CK is a muscle enzyme. In CMT2S, CK may be normal or only mildly raised, which helps distinguish it from primary muscle diseases where CK can be very high. pfmjournal.org+1
Genetic testing for CMT gene panels – A blood sample is used to analyze many CMT-related genes at once by next-generation sequencing. When IGHMBP2 mutations are found on both copies of the gene, CMT2S can be confirmed with high confidence. PubMed+2Cell+2
Targeted IGHMBP2 gene sequencing – In families where CMT2S is suspected or where a mutation was already found in a relative, direct sequencing of IGHMBP2 can be ordered. This focused test is helpful for confirming the diagnosis and for family screening. Cell+2Europe PMC+2
Nerve biopsy (rarely needed now) – In unclear cases, a small piece of nerve (usually sural nerve in the leg) may be removed and examined under the microscope. It can show axonal loss and secondary changes, but because genetic tests are now widely available, biopsy is used less often. pfmjournal.org+1
Electrodiagnostic tests
Nerve conduction studies (NCS) – Electrodes are placed on the skin to measure how fast and how strongly nerves send signals. In CMT2S, conduction velocity is often near normal or only mildly slowed, but the amplitude of responses is reduced, showing axonal loss rather than myelin damage. Cell+1
Electromyography (EMG) – A thin needle electrode is inserted into muscles to record electrical activity. EMG in CMT2S typically shows signs of chronic denervation and re-innervation, confirming that motor nerves are slowly degenerating. Cell+1
F-wave and late response studies – Special parts of nerve conduction tests look at signals traveling up and down the full length of the motor nerve. These can reveal subtle proximal involvement and further support a diagnosis of generalized axonal neuropathy. Cell+1
Imaging tests
MRI of lower limb muscles – Magnetic resonance imaging of the legs can show patterns of muscle wasting and fatty replacement typical for CMT. Certain muscle groups may be more affected, which can help distinguish CMT from other neuropathies. Muscular Dystrophy Association+1
Spine MRI (when indicated) – MRI of the spine may be done to rule out spinal cord diseases that can mimic neuropathy symptoms. A normal spinal cord image supports a peripheral nerve cause like CMT2S rather than a central nervous system disease. pfmjournal.org+1
Chest imaging or diaphragm studies (selected cases) – In patients with IGHMBP2 mutations and suspected breathing problems, chest X-ray, ultrasound, or fluoroscopy can check diaphragm movement. This is more crucial for SMARD1, but sometimes considered in the broader IGHMBP2 spectrum. JKMS+1
Goals of treatment
The main goals of treatment are:
keep muscles as strong and flexible as possible
support safe and efficient walking
prevent foot and joint deformities
control neuropathic pain and cramps
protect breathing in those with more severe weakness
support emotional health and family planning
Most care is multidisciplinary, meaning neurologists, physiotherapists, occupational therapists, orthotists, surgeons, dietitians, psychologists, and genetic counsellors work together.PMC+2Mayo Clinic+2
Non-pharmacological treatments (therapies and others)
(To stay within a readable length, this section explains 12 of the most important non-drug treatments in detail. In real care, your team may add more individual strategies.)
1. Physiotherapy (physical therapy)
Physiotherapy is a core treatment in CMT with IGHMBP2 mutation. The physiotherapist designs stretching, strengthening and balance exercises to keep muscles as strong and flexible as possible. Regular, gentle exercise helps reduce stiffness, delay contractures (when muscles and tendons shorten), and improve walking pattern. For example, calf and hamstring stretches, core stability work and resistance exercises with bands may be used. Physiotherapy also teaches safe transfer and walking techniques, which helps prevent falls and keeps the person more independent in daily life.Physiopedia+1
2. Occupational therapy
Occupational therapists focus on daily activities such as dressing, bathing, writing, using a phone and school or work tasks. They can suggest hand exercises, special pens, adapted cutlery, button hooks and computer or keyboard changes. They may also advise on home changes (grab rails, non-slip mats, shower chairs) to reduce strain and improve safety. The purpose is to help the person keep doing the things that matter to them, with less fatigue and less risk of injury.PMC
3. Ankle-foot orthoses (AFOs) and other braces
Orthotic devices such as ankle-foot orthoses (AFOs), custom shoe inserts and supportive shoes are often used in CMT. AFOs help control foot drop, keep the ankle in a stable position and improve push-off during walking. This reduces tripping, saves energy and may slow foot and ankle deformity. Orthotists choose brace types based on muscle strength, joint range and walking pattern. The goal is for the brace to feel like an extension of the body, not a burden, so careful fitting and review are important.Charcot-Marie-Tooth Association+2The Foundation for Peripheral Neuropathy+2
4. Strength and aerobic exercise programs
Supervised strength training and low-impact aerobic exercise (like walking, cycling, swimming or water aerobics) can maintain fitness without over-straining weak muscles. Exercise is usually done at moderate intensity, with rest breaks and careful monitoring for excessive fatigue or pain. The purpose is to improve endurance, heart health, mood and general function. Studies suggest that, when planned correctly, exercise is safe and beneficial in CMT.Physiopedia+1
5. Stretching and contracture prevention
Regular stretching of calves, hamstrings, hip flexors, and hand muscles helps prevent contractures that can lock joints into poor positions. The physiotherapist may teach daily home stretches, sometimes combined with night splints. Stretching works by gently lengthening the muscle-tendon units and joint capsules, giving nerves and soft tissues more room and reducing pain and stiffness.Physiopedia+1
6. Respiratory therapy and non-invasive ventilation (if needed)
If IGHMBP2-related CMT affects the diaphragm or chest muscles, a respiratory therapist may check breathing function with tests such as spirometry or overnight oximetry. Breathing exercises, cough-assist devices and non-invasive ventilation (for example BiPAP at night) can support breathing, reduce morning headaches and improve sleep quality. The purpose is to prevent lung infections and respiratory failure.Frontiers+1
7. Pain self-management strategies (including TENS)
Non-drug pain methods such as TENS (transcutaneous electrical nerve stimulation), heat packs, gentle massage, relaxation, breathing exercises and mindfulness can help some people with neuropathic and musculoskeletal pain. These methods aim to reduce pain signals going to the brain, lower muscle tension, and improve coping. They are often used together with, or sometimes instead of, medicines.PMC+1
8. Assistive devices for mobility and function
Canes, crutches, walkers and wheelchairs are tools, not failures. They help people with CMT walk further, more safely and with less fatigue. Hand splints, wrist supports, bathroom aids and adapted keyboards can protect joints and save energy in the upper limbs. The goal is to maintain independence, not to force walking without support at any cost.PMC+1
9. Fall-prevention and home safety modification
Because of foot drop, weak ankles and numbness, falls are common. Therapists can suggest removing loose rugs, improving lighting, installing grab bars and using non-slip footwear. Practicing safe turning, stair use and getting up from the floor can also help. The purpose is to avoid fractures, head injury and fear of falling, which can greatly affect quality of life.PMC+1
10. Psychological support and counseling
Living with a rare genetic disease can cause worry, sadness, anger or anxiety. Psychologists or counselors help the person and family understand the condition, cope with chronic symptoms and deal with school or work challenges. Cognitive-behavioral therapy, support groups and online communities can reduce feelings of isolation and improve overall wellbeing.PMC+1
11. Genetic counseling
Because IGHMBP2-related CMT is inherited, genetic counseling is important for family planning. A genetic counselor explains how the gene is passed on, offers testing to relatives, and discusses options such as prenatal testing or preimplantation genetic testing. The purpose is to provide clear, non-pressured information so families can make informed choices.Frontiers+1
12. Patient education and peer support networks
Organizations such as the Charcot-Marie-Tooth Association (CMTA) share trusted information, webinars and patient stories. Learning about the disease, new trials and assistive devices helps people feel more in control. Peer groups show practical tips for daily life and give emotional support from people facing similar problems.Charcot-Marie-Tooth Association+1
Drug treatments (symptom-based, not curative)
(There is no drug yet that cures IGHMBP2-related CMT. The medicines below mainly treat neuropathic pain, cramps, mood or sleep problems. Dosages are general label information; actual doses must always be decided by a doctor.)
1. Gabapentin (Neurontin)
Gabapentin is an anticonvulsant that is widely used for neuropathic pain. It binds to α2δ subunits of voltage-gated calcium channels and reduces the release of excitatory neurotransmitters, which lowers abnormal pain signaling. For neuropathic pain, adults are often started at low doses (for example 300 mg at night) and gradually increased up to around 1800–3600 mg/day in divided doses, depending on kidney function and tolerance. Common side effects include sleepiness, dizziness and unsteadiness.FDA Access Data+2FDA Access Data+2
2. Pregabalin (Lyrica)
Pregabalin is related to gabapentin and also acts on α2δ calcium channel subunits. It is approved for painful neuropathies such as diabetic neuropathy and post-herpetic neuralgia. Adults often start at about 150 mg/day divided into two or three doses, and the dose may be raised up to 300–600 mg/day if needed and tolerated. It can reduce burning, shooting pain and sleep disturbance. Side effects may include dizziness, weight gain, blurred vision and swelling of the legs.FDA Access Data+2FDA Access Data+2
3. Duloxetine
Duloxetine is a serotonin-norepinephrine reuptake inhibitor (SNRI). It increases these two neurotransmitters in the brain and spinal cord, which helps modulate pain pathways and can also treat depression and anxiety. It is licensed for painful diabetic neuropathy. Usual doses for neuropathic pain are 30–60 mg once daily. Common side effects include nausea, dry mouth, sleep changes and increased sweating.Northern Lincolnshire APC+1
4. Amitriptyline
Amitriptyline is a tricyclic antidepressant used at low doses for chronic neuropathic pain. It blocks reuptake of serotonin and norepinephrine and has additional effects on sodium channels and receptors involved in pain. Treatment often starts at 10–25 mg at night and may be slowly raised, depending on response and side effects. Dry mouth, constipation, drowsiness and weight gain are common. It is usually avoided in people with serious heart rhythm problems or glaucoma.Northern Lincolnshire APC+1
5. Nortriptyline
Nortriptyline is another tricyclic antidepressant that is sometimes better tolerated than amitriptyline. It works in a similar way, increasing serotonin and norepinephrine and affecting pain signaling. Doses are usually low at first and increased slowly. Side effects can include dry mouth, constipation, blurred vision and drowsiness. It is chosen based on individual tolerance and other medical problems.Northern Lincolnshire APC+1
6. Venlafaxine
Venlafaxine is an SNRI used mainly for depression and anxiety, but some studies suggest benefit in neuropathic pain. It raises serotonin and norepinephrine levels and may help reduce shooting and burning sensations. Doses vary widely, and treatment must be monitored for blood pressure increases, stomach upset and sleep changes. It is usually a second-line option if other first-line drugs fail.ScienceDirect
7. Topical lidocaine 5% patch
Lidocaine patches are applied to painful areas of skin. They block sodium channels in local nerves and reduce firing of damaged pain fibers. This can be helpful for focal neuropathic pain areas, for example on the feet. Patches are usually worn for up to 12 hours in 24 hours, over intact skin. Side effects are usually mild skin irritation or redness.ScienceDirect
8. Capsaicin high-concentration patch
Capsaicin works by overstimulating and then “desensitizing” certain pain fibers that carry burning and heat sensations. A high-dose patch is applied in clinic for a set time and can reduce localized neuropathic pain for weeks or months. It is more often used for post-herpetic neuralgia, but the mechanism is similar for other focal neuropathic pains. Temporary burning during and after application is common.ScienceDirect
9. Baclofen
Baclofen is a muscle-relaxing drug that activates GABA-B receptors in the spinal cord, reducing spasticity and cramps. In some people with CMT, especially when there is stiffness or spasm, baclofen can reduce painful muscle tightness and improve sleep. Doses are started low and increased slowly. Side effects include drowsiness, weakness and nausea, and sudden stopping can cause withdrawal symptoms.PMC
10. Simple analgesics (paracetamol and NSAIDs)
Paracetamol (acetaminophen) and non-steroidal anti-inflammatory drugs (like ibuprofen or naproxen) do not treat neuropathic pain very well, but they may help pain from joints, muscles and overuse due to abnormal walking. They are often used short term for flares. Side effects include liver toxicity with high-dose paracetamol and stomach, kidney or heart risks with long-term NSAIDs, so medical guidance is needed.PMC+1
11. Medicines for mood, anxiety and sleep (various classes)
Some people with CMT develop low mood, anxiety or sleep problems because of long-term symptoms. Selective serotonin reuptake inhibitors (SSRIs), SNRIs, or other sleep-aiding medicines may be used. Treating mental health does not fix the nerve damage, but it can make pain easier to cope with and improve daily function. Choice and dosing must be individualized.PMC+1
12. Drugs to avoid or use with caution
Certain chemotherapy drugs (for example vincristine) and some other medicines are known to be neurotoxic and can worsen neuropathy. Doctors managing a person with IGHMBP2-related CMT try to avoid such drugs if there is a safer alternative. Always tell any new doctor or dentist that you have CMT before starting a new medicine.PMC+1
Dietary molecular supplements
These supplements do not cure IGHMBP2-related CMT. Evidence in hereditary neuropathy is limited; many data come from general nerve-health or diabetes-related neuropathy research. Always discuss supplements with a doctor to avoid interactions.
Omega-3 fatty acids (fish oil, algae oil) – Omega-3 fats may reduce inflammation and support nerve cell membranes. They are thought to improve blood flow and reduce oxidative stress. Typical supplemental doses are often around 1–3 g of EPA+DHA per day, but this must be individualised, especially if someone uses blood thinners.
Alpha-lipoic acid – An antioxidant used in some countries for diabetic neuropathy. It may improve oxidative stress in nerves and blood vessels. Doses in studies are often around 600 mg per day, but long-term safety and benefit in CMT are less clear. Side effects can include stomach upset and, rarely, low blood sugar, so medical oversight is important.
Coenzyme Q10 (CoQ10) – CoQ10 helps mitochondria make energy. In theory it may support muscle and nerve cells that are under metabolic stress. Doses vary widely (for example 100–300 mg daily in divided doses). It is generally well tolerated but can cause digestive upset in some people.
Vitamin B12 – When B12 levels are low, nerves function poorly and neuropathy can worsen. Correcting deficiency with oral or injected B12 can improve nerve conduction in those cases. Supplement doses depend on blood levels and can be high at first, then lowered for maintenance. There is no evidence that extra B12 above normal levels improves genetic neuropathy.
Vitamin D (nutritional doses) – In people without deficiency, modest daily vitamin D (for example, in a multivitamin) supports bone and muscle health. It works by regulating calcium balance and muscle protein function. Very high doses can be toxic, so more is not always better.
Magnesium – Magnesium participates in nerve and muscle excitability. When levels are low, cramps and twitching can worsen. Dietary magnesium from nuts, seeds, and leafy greens is generally safe; supplemental doses must be adjusted in kidney disease. Too much magnesium can cause diarrhoea and, in extreme cases, heart rhythm problems.
L-carnitine – Carnitine helps shuttle fatty acids into mitochondria for energy production. Some small studies suggest it may support muscle metabolism. Doses vary; side effects can include mild nausea or a “fishy” body odour. Evidence in CMT is limited, so it should be considered experimental supportive care.
Curcumin (turmeric extract) – Curcumin has anti-inflammatory and antioxidant properties. It may reduce some inflammatory signalling in nerves and joints, but bioavailability is low, so many products mix it with piperine. Side effects include digestive upset and possible interactions with blood thinners.
Resveratrol – A plant polyphenol with antioxidant and potential neuroprotective actions in laboratory models. Human data in neuropathy are sparse. It may interact with certain medicines, so medical advice is essential.
Probiotics – The gut microbiome may affect inflammation and metabolism. Probiotics are live bacteria that aim to improve gut balance. While they do not directly target nerves, a healthier gut may support overall health and nutrient absorption, which indirectly helps long-term management.
Immunity-booster and regenerative / stem-cell-type approaches
At present there are no approved stem cell drugs or immune-booster drugs specifically for IGHMBP2-related CMT. What follows are general or experimental approaches, not routine prescriptions.
Vaccination programmes – Keeping up with recommended vaccines (flu, pneumonia, COVID-19, etc.) reduces the chance of serious infections that can worsen weakness or trigger hospitalisation. This is a practical way to “boost” protection without changing the underlying CMT.PMC
Treating vitamin and hormone deficiencies – Correcting deficiencies (for example vitamin D or thyroid hormone when truly low) strengthens general immunity and muscle function. Doctors use blood tests to guide dosing.
Gene-replacement therapy trials – As noted earlier, IGHMBP2 gene therapy in early trials attempts to deliver a healthy gene copy to nerve cells. This is regenerative in concept, aiming to improve survival and function of motor neurons. It remains available only in research settings under strict safety rules.Nationwide Children’s Hospital+1
Antisense oligonucleotide therapies – These experimental drugs aim to correct how RNA from the IGHMBP2 gene is processed, potentially restoring more normal protein levels. This is another form of regenerative molecular therapy, still in very early stages.ScienceDirect+1
Cell-based research models – Scientists use induced pluripotent stem cells (iPSCs) from patients to grow nerve cells in the lab and test new drugs. This is not a treatment given to patients yet, but it is a key stepping stone toward future regenerative therapies for IGHMBP2 disease.NMD Journal+1
General lifestyle immune support – Adequate sleep, balanced diet, stress management, and smoking avoidance support immune function. While not drugs, these behaviours help the body handle infections and surgery better, which is critical in a fragile neuromuscular condition.PMC
Surgeries
Tendon transfer surgery – Surgeons move a working tendon to take over the role of a weak muscle in the foot or ankle. The goal is to correct foot-drop or deformities like high arches, improve walking, and reduce the need for bracing. The mechanism is mechanical re-balancing of forces around the joint.Charcot-Marie-Tooth Disease+1
Osteotomy (bone cutting and reshaping) – In severe deformities, bones in the foot may be cut and repositioned to restore a more normal shape. This improves weight distribution, helps shoes fit better, and lowers pain.
Arthrodesis (joint fusion, such as triple arthrodesis) – When deformities are fixed and joints are unstable and painful, fusing certain joints can provide a stable, plantigrade foot. The purpose is pain relief and better standing balance, accepting some loss of motion.Charcot-Marie-Tooth Disease
Spine surgery for scoliosis – Some people with neuromuscular weakness develop scoliosis. If the curve progresses and affects posture or breathing, spinal fusion may be considered. The aim is to stabilise the spine, improve sitting balance, and protect lung function.PMC+1
Procedures to support breathing (for severe cases) – In IGHMBP2 disorders with major respiratory involvement, long-term ventilation through a tracheostomy may sometimes be needed. The purpose is to secure the airway and allow safe, continuous breathing support. This is more typical of SMARD1-like forms but is part of the same gene-related spectrum.PMC+1
Preventions
You cannot presently prevent being born with an IGHMBP2 mutation, but many complications can be reduced:
Avoid unnecessary weight gain – Protects joints and lowers strain on weak feet and ankles.
Use braces and orthotics early when advised – Helps prevent fixed deformities and chronic sprains.Mayo Clinic+1
Do regular physiotherapy and stretching – Lowers risk of contractures and severe stiffness.nhs.uk+1
Protect feet and skin – Daily foot checks, good shoes, and quick care of blisters prevent ulcers and infections.
Reduce fall risk at home – Clear clutter, use good lighting, and install grab bars where needed.
Keep vaccinations up to date – Lowers chance of severe infections that might worsen weakness.
Treat pain early and appropriately – Prevents chronic pain cycles and secondary depression.
Monitor breathing and spine – Regular check-ups can catch scoliosis or breathing decline early.MDPI+1
Genetic counselling for family planning – Can help at-risk couples consider options before pregnancy.Frontiers+1
Avoid smoking and heavy alcohol use – Both can worsen nerve damage and overall health.PMC
When to see doctors
You should see a neurologist or neuromuscular specialist:
when there is new weakness, especially rapid change in walking, hand use, or breathing
if you notice frequent falls, ankle sprains, or worsening foot deformity
when pain is strong, constant, or not controlled with simple measures
if you have night-time shortness of breath, shallow breathing, morning headaches, or daytime sleepiness, which can signal breathing muscle weakness
when there are signs of depression or anxiety affecting daily life
before planning a pregnancy, to discuss genetic risks and testing options
regularly, even when stable, to review braces, therapy, and any new research or trial options
Emergency care is needed for sudden severe breathing trouble, chest pain, high fever with weakness, or rapid loss of walking ability.Mayo Clinic+2PMC+2
What to eat and what to avoid
What to eat (supportive):
Plenty of vegetables and fruits – Provide vitamins, minerals, and antioxidants that support general tissue health and immunity.
Lean proteins – Fish, poultry, beans, and lentils help maintain muscle mass and repair tissues.
Whole grains – Brown rice, oats, whole-wheat bread give steady energy and support a healthy weight.
Healthy fats – Nuts, seeds, olive oil, and fatty fish supply omega-3s and help reduce inflammation.
Calcium- and vitamin-D-rich foods – Dairy, fortified plant milks, and leafy greens support bones, which is important when mobility is reduced.PMC
What to limit or avoid:
Sugary drinks and sweets – They add calories without nutrients and can lead to weight gain and insulin resistance.
Highly processed snacks and fast food – Often high in salt, unhealthy fats, and additives that do not support long-term health.
Excess alcohol – Can worsen neuropathy and interact with medicines.
Very high-salt foods – Can increase blood pressure and swelling, especially if pain drugs already affect kidneys.
Smoking and vaping products – Not food, but important to avoid because they harm blood vessels and nerves.PMC
Frequently asked questions
1. Is IGHMBP2-related CMT the same as usual CMT?
No. It is one of many genetic subtypes, called CMT2S. It shares features like distal weakness and sensory loss, but it is specifically linked to recessive mutations in the IGHMBP2 gene and may overlap with SMARD1-like respiratory problems.Frontiers+1
2. Can this disease be cured today?
At present, there is no cure. Treatments focus on symptoms, maintaining function, and preventing complications. Gene-based therapies are under research, but they are not yet standard care.PMC+2ScienceDirect+2
3. Will everyone with IGHMBP2 mutation have the same severity?
No. Even with the same gene, severity can vary widely. Some people have mainly foot weakness and live fairly active lives; others, especially with SMARD1-like forms, can have severe early breathing problems.PMC+2Nature+2
4. How is the diagnosis confirmed?
Doctors suspect CMT from symptoms, nerve conduction studies, and family history. The diagnosis of IGHMBP2-related disease is confirmed by genetic testing that finds disease-causing variants in the IGHMBP2 gene.Frontiers+1
5. Why is physiotherapy so important?
Physiotherapy keeps muscles flexible and joints mobile, reduces pain and stiffness, and helps maintain balance and walking ability. It cannot fix the gene but slows secondary problems like contractures and deformities.nhs.uk+1
6. Do braces mean the disease is getting worse?
Not always. Braces can be introduced early to protect joints, prevent falls, and save energy. Many people walk better and for longer years because they start bracing sooner, not later.Mayo Clinic+1
7. Are neuropathic pain drugs safe for long-term use?
Gabapentin, pregabalin, duloxetine, and tricyclics have been used long term in many neuropathic pain conditions. However, side effects and interactions are common, so regular medical review is essential. Doses must never be changed without medical advice, especially in young people.DrugBank+3FDA Access Data+3FDA Access Data+3
8. Should I take many supplements to help my nerves?
Supplements may help if a true deficiency exists, but taking many products without testing can waste money and sometimes cause harm. The safest approach is to test for deficiencies and then use targeted supplements under medical supervision.PMC
9. Can pregnancy be safe with IGHMBP2-related CMT?
Many people with CMT have successful pregnancies, but careful planning is important. Genetic counselling explains risks to the baby, and obstetric and anaesthetic teams can plan for delivery and possible breathing or mobility needs.Frontiers+1
10. Will my children definitely have the disease?
IGHMBP2-related CMT is usually autosomal recessive. This means both parents must carry a faulty copy for a child to be affected. A genetic counsellor can explain exact risks for each family based on test results.Frontiers+1
11. Is it safe to play sports?
Light to moderate, low-impact sports are usually encouraged, as they help fitness and mood. High-impact or contact sports that risk falls or ankle injuries may not be suitable. A physiotherapist can suggest safe activities for each person.Physiopedia+1
12. How often should I have follow-up visits?
This depends on age and severity, but many specialists recommend at least yearly reviews, and more often when symptoms are changing, new braces are needed, or trials are being considered.PMC+1
13. Are there special precautions for surgery or anaesthesia?
Yes. The anaesthesia team should know about the neuromuscular condition, breathing status, and any heart or lung issues. They may adjust drug choices and monitoring to keep things safe.MDPI+1
14. Can gene therapy completely reverse the disease in the future?
We do not know yet. Early research is promising in animal models and very early human work, but it is unclear how much function can be restored, especially in long-damaged nerves. It is more realistic to hope for slowing or partial improvement than a full reversal.ScienceDirect+2Nationwide Children’s Hospital+2
15. What is the most important thing I can do right now?
The most helpful steps usually are: stay linked with a neuromuscular team, keep up with physiotherapy and braces, protect healthy weight and lifestyle, manage pain and mood early, and consider genetic counselling. These actions do not cure the disease but protect your function and quality of life over the long term.PMC+2Mayo Clinic+2
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members
Last Updated: December 22, 2025.
